COMMUNIQUÉS West-GlobeNewswire
-
Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference
28/08/2024 - 22:01 -
PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024
28/08/2024 - 22:03 -
Aura Biosciences to Participate in Upcoming Investor Conferences
28/08/2024 - 22:05 -
QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in chronic diseases
28/08/2024 - 22:05 -
ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
28/08/2024 - 22:05 -
Inotiv to Participate in the 8th Annual Lake Street Best Ideas Growth Conference
28/08/2024 - 22:05 -
Lyell Immunopharma Announces Participation in September Investor Conferences
28/08/2024 - 22:05 -
Akero Therapeutics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
28/08/2024 - 22:05 -
CooperCompanies Announces Third Quarter 2024 Results
28/08/2024 - 22:15 -
Supernus Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
28/08/2024 - 22:15 -
iTeos to Participate in Upcoming Investor Conferences
28/08/2024 - 22:30 -
Spectral AI to Participate in Upcoming Investor Conferences
28/08/2024 - 22:30 -
Celularity Appoints Richard J. Berman to its Board of Directors
28/08/2024 - 22:45 -
Foundation for Sarcoidosis Research Expands Scientific Advisory Board with 14 New Experts to Enhance Sarcoidosis Research and Patient Care
28/08/2024 - 22:48 -
CAMP4 Therapeutics Secures Rare Pediatric Disease Designation for CMP-CPS-001 for the Treatment of Urea Cycle Disorders
27/08/2024 - 14:00 -
Centessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)
27/08/2024 - 14:00 -
Spectral AI Completes Burn Center Enrollment for U.S. Burn Pivotal Study
27/08/2024 - 14:00 -
Soleno Therapeutics Announces U.S. FDA Acceptance for Filing and Priority Review of NDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome
27/08/2024 - 14:00 -
Korro to Participate in Upcoming September Investor and Scientific Conferences
27/08/2024 - 14:00
Pages